These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27097163)

  • 21. Association between SLC11A1 polymorphisms and susceptibility to different clinical forms of tuberculosis in the Peruvian population.
    Taype CA; Castro JC; Accinelli RA; Herrera-Velit P; Shaw MA; Espinoza JR
    Infect Genet Evol; 2006 Sep; 6(5):361-7. PubMed ID: 16461017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.
    Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D
    Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paediatric Buruli ulcer in Australia.
    Walker G; Friedman DN; O'Brien MP; Cooper C; McDonald A; Callan P; O'Brien DP
    J Paediatr Child Health; 2020 Apr; 56(4):636-641. PubMed ID: 31821679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between SLC11A1 (NRAMP1) polymorphisms and susceptibility to tuberculosis in Chinese Holstein cattle.
    Liu K; Zhang B; Teng Z; Wang Y; Dong G; Xu C; Qin B; Song C; Chai J; Li Y; Shi X; Shu X; Zhang Y
    Tuberculosis (Edinb); 2017 Mar; 103():10-15. PubMed ID: 28237028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLC11A1 (formerly NRAMP1) polymorphisms associated with multidrug-resistant tuberculosis.
    Takahashi K; Hasegawa Y; Abe T; Yamamoto T; Nakashima K; Imaizumi K; Shimokata K
    Tuberculosis (Edinb); 2008 Jan; 88(1):52-7. PubMed ID: 17950034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnopharmacological reports on anti-Buruli ulcer medicinal plants in three West African countries.
    Tsouh Fokou PV; Nyarko AK; Appiah-Opong R; Tchokouaha Yamthe LR; Addo P; Asante IK; Boyom FF
    J Ethnopharmacol; 2015 Aug; 172():297-311. PubMed ID: 26099634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway.
    Manry J; Vincent QB; Johnson C; Chrabieh M; Lorenzo L; Theodorou I; Ardant MF; Marion E; Chauty A; Marsollier L; Abel L; Alcaïs A
    Commun Biol; 2020 Apr; 3(1):177. PubMed ID: 32313116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human genetics of mycobacterial disease.
    Dallmann-Sauer M; Correa-Macedo W; Schurr E
    Mamm Genome; 2018 Aug; 29(7-8):523-538. PubMed ID: 30116885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa.
    Hoal EG; Lewis LA; Jamieson SE; Tanzer F; Rossouw M; Victor T; Hillerman R; Beyers N; Blackwell JM; Van Helden PD
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1464-71. PubMed ID: 15636493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buruli ulcer in Nigeria: results of a pilot case study in three rural districts.
    Ukwaja KN; Meka AO; Chukwuka A; Asiedu KB; Huber KL; Eddyani M; Chukwu JN; Anyim MC; Nwafor CC; Oshi DC; Madichie NO; Ekeke N; Njoku M; Ntana K
    Infect Dis Poverty; 2016 Apr; 5():39. PubMed ID: 27105826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management.
    Simoes S; Carvalheiro M; Gaspar MM
    Curr Pharm Des; 2016; 22(43):6577-6586. PubMed ID: 27396598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods used in preclinical assessment of anti-Buruli ulcer agents: A global perspective.
    Tsouh PV; Addo P; Yeboah-Manu D; Boyom FF
    J Pharmacol Toxicol Methods; 2015; 73():27-33. PubMed ID: 25792087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).
    Kibadi K; Boelaert M; Fraga AG; Kayinua M; Longatto-Filho A; Minuku JB; Mputu-Yamba JB; Muyembe-Tamfum JJ; Pedrosa J; Roux JJ; Meyers WM; Portaels F
    PLoS Negl Trop Dis; 2010 Jul; 4(7):e736. PubMed ID: 20625556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.
    Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA
    Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.
    O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Walton A; Athan E
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006357. PubMed ID: 29554101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in leprosy and Buruli ulcer (Mycobacterium ulcerans infection).
    Walsh DS; Portaels F; Meyers WM
    Curr Opin Infect Dis; 2010 Oct; 23(5):445-55. PubMed ID: 20581668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of the NRAMP1 gene: distribution and susceptibility to the development of pulmonary tuberculosis in the Greek population.
    Stagas MK; Papaetis GS; Orphanidou D; Kostopoulos C; Syriou S; Reczko M; Drakoulis N
    Med Sci Monit; 2011 Jan; 17(1):PH1-6. PubMed ID: 21169917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection.
    de Zeeuw J; Duggirala S; Nienhuis WA; Abass KM; Tuah W; Omansen TF; van der Werf TS; Stienstra Y
    Am J Trop Med Hyg; 2013 Sep; 89(3):498-500. PubMed ID: 23836576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.
    Sarpong-Duah M; Frimpong M; Beissner M; Saar M; Laing K; Sarpong F; Loglo AD; Abass KM; Frempong M; Sarfo FS; Bretzel G; Wansbrough-Jones M; Phillips RO
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005695. PubMed ID: 28671942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bifocal Buruli ulcer: multiple cephalic lesions after initiation of medical treatment].
    Vagamon B; Ahogo KC; Aka BR; Diabaté A; Kouassi YI; Kourouma SH; Traoré C; Gue I; Yoboue P; Kanga JM; Taieb A
    Ann Dermatol Venereol; 2013 Feb; 140(2):125-8. PubMed ID: 23395495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.